Skip to main content

Table 3 Quality assessment of vaccine trials for immunization against – ETEC

From: Vaccines for the prevention of diarrhea due to cholera, shigella, ETEC and rotavirus

Results for ETEC
Outcomes No of Studies No of Participants Impact Estimates (95% CI)
Serum Ig A seroconversion 2 [42, 47] 157 2.70 [1.87, 3.90]a
Serum Ig G seroconversion 2 [42, 47] 157 4.99 [2.51, 9.92]a
Adverse Events 4 [43, 44, 46, 47] 1169 1.58 (1.14, 2.19)a
  1. a: Fixed Effect Model
  2. b: Random Effect Model